Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at an average $23.18 ($278,210)
  2. 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $23.18 ($98,530)
  3. 4 Planned sale Director sold 1,270 shares at $23.74 ($30,150)
  4. 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
  5. 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
  6. 4 Planned sale CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)
  7. 4 Planned sale CHIEF OPERATING OFFICER sold 260 shares at $25.06 ($6,515)
  8. 4 Planned sale CHIEF OPERATING OFFICER sold 4,875 shares at $22.72 ($110,769)
  9. 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.50 ($22,500)
  10. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 12,000 shares at an average $17.92 ($214,988)
  11. 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $16.97 ($55,165)
  12. 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at $16.89 ($202,700)
  13. 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $25.03 ($438,099)
  14. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 30,000 shares at $25.04 ($751,332)
  15. 4 Planned sale PRESIDENT AND CEO sold 47,709 shares at $25.04 ($1,194,700)
  16. 4 Planned sale CHIEF FINANCIAL OFFICER sold 14,000 shares at an average $24.72 ($346,149)
  17. 4 Planned sale Director sold 6,964 shares at an average $24.11 ($167,888)
  18. 4 Planned sale CHIEF MEDICAL OFFICER sold 20,000 shares at $25.07 ($501,478)
  19. 4 Planned sale Director sold 67,000 shares at an average $23.36 ($1,564,812)
  20. 4 Derivatives Options or other derivatives

Page 9 of 20 · 383 filings